Arthur S. Kirsch - 07 Jul 2026 Form 4 Insider Report for Evommune, Inc. (EVMN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jul 2026, 20:00:20 UTC
Prior SEC filing
23 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Arthur S. Kirsch filed Form 4 for Evommune, Inc. (EVMN) on 08 Jul 2026.

Key facts

  • This page summarizes Arthur S. Kirsch's Form 4 filing for Evommune, Inc. (EVMN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jul 2026, 20:00.

Change

  • Previous filing in this sequence was filed on 23 Jun 2026.
  • Current net transaction value: +$133,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001290976 Primary reporting owner

KIRSCH ARTHUR S

Relationship
Director
Address
C/O EVOMMUNE, INC., 1891 PAGE MILL ROAD, PALO ALTO
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
Signature date
08 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVMN transaction

Common Stock

Purchase

Transaction value
$133,000
Shares
+10,000
Change %
Price
$13.30
Shares after
10,000
Date
07 Jul 2026
Ownership
By Trust
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.25 to $13.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .